ohai.social

UK<a href="https://www.europesays.com/uk/45209/" rel="nofollow noopener" translate="no" target="_blank">https://www.europesays.com/uk/45209/</a> PGxAI Unveils AI Genetic Tool to Personalize GLP-1 Treatment <a href="https://pubeurope.com/tags/ArtificialIntelligence" class="mention hashtag" rel="nofollow noopener" target="_blank">#ArtificialIntelligence</a> <a href="https://pubeurope.com/tags/Genetics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetics</a> <a href="https://pubeurope.com/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://pubeurope.com/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://pubeurope.com/tags/UK" class="mention hashtag" rel="nofollow noopener" target="_blank">#UK</a> <a href="https://pubeurope.com/tags/UnitedKingdom" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedKingdom</a>

N Jay SorensenGLP-1s aren’t just shifting waistlines—they’re reshaping grocery carts. 🍎🛒As an RDN, I see an urgent opportunity: guide consumers toward sustainable changes—nutrient density, satiety, less ultra-processing.Retailers must rethink how they promote food for health.<a href="https://mastodon.social/tags/PublicHealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#PublicHealth</a> <a href="https://mastodon.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://mastodon.social/tags/FoodRetail" class="mention hashtag" rel="nofollow noopener" target="_blank">#FoodRetail</a> <a href="https://mastodon.social/tags/RDNsLead" class="mention hashtag" rel="nofollow noopener" target="_blank">#RDNsLead</a> <a href="https://mastodon.social/tags/NutritionEquity" class="mention hashtag" rel="nofollow noopener" target="_blank">#NutritionEquity</a> <a href="https://mastodon.social/tags/ConsumerBehavior" class="mention hashtag" rel="nofollow noopener" target="_blank">#ConsumerBehavior</a> <a href="https://www.smartbrief.com/original/the-impact-of-glp-1s-on-food-retailers-and-how-theyre-responding" rel="nofollow noopener" translate="no" target="_blank">https://www.smartbrief.com/original/the-impact-of-glp-1s-on-food-retailers-and-how-theyre-responding</a>

GeekooA new study reveals a rapid shift towards GLP-1 drugs for weight loss and diabetes, signaling a transformative change in treatment approaches. <a href="https://mastodon.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://mastodon.social/tags/WeightLoss" class="mention hashtag" rel="nofollow noopener" target="_blank">#WeightLoss</a> <a href="https://mastodon.social/tags/DiabetesCare" class="mention hashtag" rel="nofollow noopener" target="_blank">#DiabetesCare</a><a href="https://geekoo.news/the-new-era-of-weight-loss-glp-1-drugs-take-center-stage/" rel="nofollow noopener" translate="no" target="_blank">https://geekoo.news/the-new-era-of-weight-loss-glp-1-drugs-take-center-stage/</a>

N Jay SorensenFrom protein to probiotics, functional foods are evolving. 🥦🧬 Consumers want gut health, weight support & immunity—all in one bite. Products like Nestlé’s Vital Pursuit show the future of targeted nutrition. Let’s make it evidence-based & equitable. <a href="https://mastodon.social/tags/FunctionalFoods" class="mention hashtag" rel="nofollow noopener" target="_blank">#FunctionalFoods</a> <a href="https://mastodon.social/tags/RDNsLead" class="mention hashtag" rel="nofollow noopener" target="_blank">#RDNsLead</a> <a href="https://mastodon.social/tags/GutHealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#GutHealth</a> <a href="https://mastodon.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://mastodon.social/tags/NutritionMatters" class="mention hashtag" rel="nofollow noopener" target="_blank">#NutritionMatters</a> <a href="https://www.foodnavigator.com/Article/2025/04/09/demand-for-functional-ingredients-to-meet-health-needs/" rel="nofollow noopener" translate="no" target="_blank">https://www.foodnavigator.com/Article/2025/04/09/demand-for-functional-ingredients-to-meet-health-needs/</a>

UK<a href="https://www.europesays.com/uk/29734/" rel="nofollow noopener" translate="no" target="_blank">https://www.europesays.com/uk/29734/</a> GLP1 agonists linked to depression risk in new genetic study <a href="https://pubeurope.com/tags/addiction" class="mention hashtag" rel="nofollow noopener" target="_blank">#addiction</a> <a href="https://pubeurope.com/tags/Chronic" class="mention hashtag" rel="nofollow noopener" target="_blank">#Chronic</a> <a href="https://pubeurope.com/tags/Depression" class="mention hashtag" rel="nofollow noopener" target="_blank">#Depression</a> <a href="https://pubeurope.com/tags/Dopamine" class="mention hashtag" rel="nofollow noopener" target="_blank">#Dopamine</a> <a href="https://pubeurope.com/tags/Drugs" class="mention hashtag" rel="nofollow noopener" target="_blank">#Drugs</a> <a href="https://pubeurope.com/tags/Genes" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genes</a> <a href="https://pubeurope.com/tags/Genetic" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetic</a> <a href="https://pubeurope.com/tags/Genetics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetics</a> <a href="https://pubeurope.com/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://pubeurope.com/tags/Glucagon" class="mention hashtag" rel="nofollow noopener" target="_blank">#Glucagon</a> <a href="https://pubeurope.com/tags/GlucagonLikePeptide1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GlucagonLikePeptide1</a> <a href="https://pubeurope.com/tags/Medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#Medicine</a> <a href="https://pubeurope.com/tags/neuropharmacology" class="mention hashtag" rel="nofollow noopener" target="_blank">#neuropharmacology</a> <a href="https://pubeurope.com/tags/Receptor" class="mention hashtag" rel="nofollow noopener" target="_blank">#Receptor</a> <a href="https://pubeurope.com/tags/Research" class="mention hashtag" rel="nofollow noopener" target="_blank">#Research</a> <a href="https://pubeurope.com/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://pubeurope.com/tags/SubstanceUseDisorder" class="mention hashtag" rel="nofollow noopener" target="_blank">#SubstanceUseDisorder</a> <a href="https://pubeurope.com/tags/UK" class="mention hashtag" rel="nofollow noopener" target="_blank">#UK</a> <a href="https://pubeurope.com/tags/UnitedKingdom" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedKingdom</a>

Dr. Lukas MorcinekOzempic & vision loss? 👁️ 7 rare cases of optic nerve stroke (NAION) raise concern. ⚠️ Link suspected, not proven. Don’t panic—stay informed. See an eye doctor if vision changes! <a href="https://mastodon.social/tags/Ozempic" class="mention hashtag" rel="nofollow noopener" target="_blank">#Ozempic</a> <a href="https://mastodon.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://mastodon.social/tags/EyeHealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#EyeHealth</a> <a href="https://mastodon.social/tags/Longevity" class="mention hashtag" rel="nofollow noopener" target="_blank">#Longevity</a><a href="https://www.youtube.com/watch?v=u_-GS48rQhs&list=PLCFAL8lW1qRcyFIOikD6P0TkXz8YNQBKT&index=3" rel="nofollow noopener" translate="no" target="_blank">https://www.youtube.com/watch?v=u_-GS48rQhs&list=PLCFAL8lW1qRcyFIOikD6P0TkXz8YNQBKT&index=3</a>

GeekooNew study led by Galway undergrads links GLP-1 diabetes drugs to 45% lower dementia risk. Could this reshape prevention strategies? <a href="https://mastodon.social/tags/DiabetesResearch" class="mention hashtag" rel="nofollow noopener" target="_blank">#DiabetesResearch</a> <a href="https://mastodon.social/tags/DementiaPrevention" class="mention hashtag" rel="nofollow noopener" target="_blank">#DementiaPrevention</a> <a href="https://mastodon.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a><a href="https://geekoo.news/diabetes-drug-class-linked-to-reduced-dementia-risk/" rel="nofollow noopener" translate="no" target="_blank">https://geekoo.news/diabetes-drug-class-linked-to-reduced-dementia-risk/</a>

JB aka J LeeThe next big workplace battle is whether employers should pay for Ozempic. As costs soar and generics loom, the fight over GLP-1 coverage is heating up. <a href="https://mastodon.social/tags/HR" class="mention hashtag" rel="nofollow noopener" target="_blank">#HR</a> <a href="https://mastodon.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://buff.ly/343yl8n" rel="nofollow noopener" translate="no" target="_blank">https://buff.ly/343yl8n</a>

N Jay Sorensen📊 Data-driven nutrition is shaping the future!Danone is leveraging insights to align with weight-loss trends & GLP-1 medications, ensuring nutrient-dense, protein-rich options meet evolving needs. Smart data = smarter food choices!💡 What’s your take? <a href="https://mastodon.social/tags/NutritionInnovation" class="mention hashtag" rel="nofollow noopener" target="_blank">#NutritionInnovation</a> <a href="https://mastodon.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://mastodon.social/tags/FoodTrends" class="mention hashtag" rel="nofollow noopener" target="_blank">#FoodTrends</a> <a href="https://mastodon.social/tags/DataDrivenHealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#DataDrivenHealth</a> <a href="https://consumergoods.com/danone-wells-enterprises-harness-consumer-data-uncover-trends-optimize-promotions" rel="nofollow noopener" translate="no" target="_blank">https://consumergoods.com/danone-wells-enterprises-harness-consumer-data-uncover-trends-optimize-promotions</a>

Bytes EuropeHealthcare groups urge FDA to act on compounding regulations after GLP-1 medicine shortages <a href="https://www.byteseu.com/855631/" rel="nofollow noopener" translate="no" target="_blank">https://www.byteseu.com/855631/</a> #<a href="https://pubeurope.com/tags/WomensHealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#WomensHealth</a> <a href="https://pubeurope.com/tags/diabetes" class="mention hashtag" rel="nofollow noopener" target="_blank">#diabetes</a> <a href="https://pubeurope.com/tags/EDUCATION" class="mention hashtag" rel="nofollow noopener" target="_blank">#EDUCATION</a> <a href="https://pubeurope.com/tags/Food" class="mention hashtag" rel="nofollow noopener" target="_blank">#Food</a> <a href="https://pubeurope.com/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://pubeurope.com/tags/Health" class="mention hashtag" rel="nofollow noopener" target="_blank">#Health</a> <a href="https://pubeurope.com/tags/Healthcare" class="mention hashtag" rel="nofollow noopener" target="_blank">#Healthcare</a> <a href="https://pubeurope.com/tags/Medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#Medicine</a> <a href="https://pubeurope.com/tags/Obesity" class="mention hashtag" rel="nofollow noopener" target="_blank">#Obesity</a> <a href="https://pubeurope.com/tags/semaglutide" class="mention hashtag" rel="nofollow noopener" target="_blank">#semaglutide</a> <a href="https://pubeurope.com/tags/WeightLoss" class="mention hashtag" rel="nofollow noopener" target="_blank">#WeightLoss</a>

Europe Says<a href="https://www.europesays.com/1935241/" rel="nofollow noopener" translate="no" target="_blank">https://www.europesays.com/1935241/</a> Healthcare groups urge FDA to act on compounding regulations after GLP-1 medicine shortages <a href="https://pubeurope.com/tags/america" class="mention hashtag" rel="nofollow noopener" target="_blank">#america</a> <a href="https://pubeurope.com/tags/diabetes" class="mention hashtag" rel="nofollow noopener" target="_blank">#diabetes</a> <a href="https://pubeurope.com/tags/education" class="mention hashtag" rel="nofollow noopener" target="_blank">#education</a> <a href="https://pubeurope.com/tags/Entertainment" class="mention hashtag" rel="nofollow noopener" target="_blank">#Entertainment</a> <a href="https://pubeurope.com/tags/Food" class="mention hashtag" rel="nofollow noopener" target="_blank">#Food</a> <a href="https://pubeurope.com/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://pubeurope.com/tags/health" class="mention hashtag" rel="nofollow noopener" target="_blank">#health</a> <a href="https://pubeurope.com/tags/healthcare" class="mention hashtag" rel="nofollow noopener" target="_blank">#healthcare</a> <a href="https://pubeurope.com/tags/medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#medicine</a> <a href="https://pubeurope.com/tags/obesity" class="mention hashtag" rel="nofollow noopener" target="_blank">#obesity</a> <a href="https://pubeurope.com/tags/Semaglutide" class="mention hashtag" rel="nofollow noopener" target="_blank">#Semaglutide</a> <a href="https://pubeurope.com/tags/sports" class="mention hashtag" rel="nofollow noopener" target="_blank">#sports</a> <a href="https://pubeurope.com/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedStates</a> <a href="https://pubeurope.com/tags/UnitedStatesOfAmerica" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedStatesOfAmerica</a> <a href="https://pubeurope.com/tags/US" class="mention hashtag" rel="nofollow noopener" target="_blank">#US</a> <a href="https://pubeurope.com/tags/USA" class="mention hashtag" rel="nofollow noopener" target="_blank">#USA</a> <a href="https://pubeurope.com/tags/WeightLoss" class="mention hashtag" rel="nofollow noopener" target="_blank">#WeightLoss</a> <a href="https://pubeurope.com/tags/Women" class="mention hashtag" rel="nofollow noopener" target="_blank">#Women</a>'sHealth

DrBob, Neurologist, 🧠MechanicGLP-1s Are Crazy Effective — Just Not Cost-EffectiveI’ll make the argument that the most effective drugs in the past decade are the GLP-1 receptor agonists, drugs like semaglutide and tirzepatide. At least in terms of weight loss, they are truly unparalleled. They are clearly effective. But are they worth it? Are they cost-effective? That is a much harder question, and, as you’ll see in a minute, despite their amazing effects, the answer — for now, at least — is no.<a href="https://vmst.io/tags/mounjaro" class="mention hashtag" rel="nofollow noopener" target="_blank">#mounjaro</a> <a href="https://vmst.io/tags/ozempic" class="mention hashtag" rel="nofollow noopener" target="_blank">#ozempic</a> <a href="https://vmst.io/tags/zepbound" class="mention hashtag" rel="nofollow noopener" target="_blank">#zepbound</a> <a href="https://vmst.io/tags/wegovy" class="mention hashtag" rel="nofollow noopener" target="_blank">#wegovy</a> <a href="https://vmst.io/tags/glp1" class="mention hashtag" rel="nofollow noopener" target="_blank">#glp1</a> <a href="https://www.medscape.com/viewarticle/glp-1s-are-crazy-effective-just-not-cost-effective-2025a10006es?form=fpf" rel="nofollow noopener" translate="no" target="_blank">https://www.medscape.com/viewarticle/glp-1s-are-crazy-effective-just-not-cost-effective-2025a10006es?form=fpf</a>

Yonhap Infomax NewsNovo Nordisk's ADR rises 1.04% to $80.98 following UBS's positive assessment and buy recommendation, despite overall market decline, as competition in obesity treatment market intensifies. <a href="https://mastodon.social/tags/YonhapInfomax" class="mention hashtag" rel="nofollow noopener" target="_blank">#YonhapInfomax</a> <a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener" target="_blank">#NovoNordisk</a> <a href="https://mastodon.social/tags/ADR" class="mention hashtag" rel="nofollow noopener" target="_blank">#ADR</a> <a href="https://mastodon.social/tags/UBS" class="mention hashtag" rel="nofollow noopener" target="_blank">#UBS</a> <a href="https://mastodon.social/tags/ObesityTreatment" class="mention hashtag" rel="nofollow noopener" target="_blank">#ObesityTreatment</a> <a href="https://mastodon.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://mastodon.social/tags/Economics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Economics</a> <a href="https://mastodon.social/tags/FinancialMarkets" class="mention hashtag" rel="nofollow noopener" target="_blank">#FinancialMarkets</a> <a href="https://mastodon.social/tags/Banking" class="mention hashtag" rel="nofollow noopener" target="_blank">#Banking</a> <a href="https://mastodon.social/tags/Securities" class="mention hashtag" rel="nofollow noopener" target="_blank">#Securities</a> <a href="https://mastodon.social/tags/Bonds" class="mention hashtag" rel="nofollow noopener" target="_blank">#Bonds</a> <a href="https://mastodon.social/tags/StockMarket" class="mention hashtag" rel="nofollow noopener" target="_blank">#StockMarket</a> <a href="https://en.infomaxai.com/news/articleView.html?idxno=54698" rel="nofollow noopener" translate="no" target="_blank">https://en.infomaxai.com/news/articleView.html?idxno=54698</a>

Howard Smith MD, AMDiabetes Under Better Control: Diabetes-related deaths dropped by 32% from 2000 to 2019. <a href="https://masto.nyc/tags/diabetes" class="mention hashtag" rel="nofollow noopener" target="_blank">#diabetes</a> <a href="https://masto.nyc/tags/mortality" class="mention hashtag" rel="nofollow noopener" target="_blank">#mortality</a> <a href="https://masto.nyc/tags/insulins" class="mention hashtag" rel="nofollow noopener" target="_blank">#insulins</a> <a href="https://masto.nyc/tags/glp1" class="mention hashtag" rel="nofollow noopener" target="_blank">#glp1</a> <a href="https://masto.nyc/tags/latino" class="mention hashtag" rel="nofollow noopener" target="_blank">#latino</a> <a href="https://masto.nyc/tags/black" class="mention hashtag" rel="nofollow noopener" target="_blank">#black</a> <a href="https://masto.nyc/tags/nativeamericans" class="mention hashtag" rel="nofollow noopener" target="_blank">#nativeamericans</a> <a href="https://masto.nyc/tags/alaskannative" class="mention hashtag" rel="nofollow noopener" target="_blank">#alaskannative</a> <a href="https://masto.nyc/tags/asian" class="mention hashtag" rel="nofollow noopener" target="_blank">#asian</a> <a href="https://masto.nyc/tags/white" class="mention hashtag" rel="nofollow noopener" target="_blank">#white</a> <a href="https://www.instagram.com/reel/DHWqGMHsxHy/" rel="nofollow noopener" translate="no" target="_blank">https://www.instagram.com/reel/DHWqGMHsxHy/</a>

Bytes EuropeScientists Discover Potential Ozempic Rival That Could Help People Lose Weight With Less Nausea <a href="https://www.byteseu.com/835473/" rel="nofollow noopener" translate="no" target="_blank">https://www.byteseu.com/835473/</a> <a href="https://pubeurope.com/tags/ExperimentalDrugs" class="mention hashtag" rel="nofollow noopener" target="_blank">#ExperimentalDrugs</a> <a href="https://pubeurope.com/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://pubeurope.com/tags/Obesity" class="mention hashtag" rel="nofollow noopener" target="_blank">#Obesity</a> <a href="https://pubeurope.com/tags/Ozempic" class="mention hashtag" rel="nofollow noopener" target="_blank">#Ozempic</a> <a href="https://pubeurope.com/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://pubeurope.com/tags/semaglutide" class="mention hashtag" rel="nofollow noopener" target="_blank">#semaglutide</a> <a href="https://pubeurope.com/tags/Wegovy" class="mention hashtag" rel="nofollow noopener" target="_blank">#Wegovy</a> <a href="https://pubeurope.com/tags/WeightLoss" class="mention hashtag" rel="nofollow noopener" target="_blank">#WeightLoss</a>

kurtshAs someone actively on a GLP-1 as a diabetic, this explainer around the economics of these drugs is both fascinating & maddening. ✅ The Ozempocalypse Is Nigh - by Scott Alexander <a href="https://www.astralcodexten.com/p/the-ozempocalypse-is-nigh" rel="nofollow noopener" translate="no" target="_blank">https://www.astralcodexten.com/p/the-ozempocalypse-is-nigh</a> <a href="https://mastodon.social/tags/glp1" class="mention hashtag" rel="nofollow noopener" target="_blank">#glp1</a> <a href="https://mastodon.social/tags/ozempic" class="mention hashtag" rel="nofollow noopener" target="_blank">#ozempic</a> <a href="https://mastodon.social/tags/semaglutide" class="mention hashtag" rel="nofollow noopener" target="_blank">#semaglutide</a>

scinexx - das wissensmagazinPotenzielle Alternative? Mediziner haben ein natürliches Molekül entdeckt, das ähnlich wirkt wie Ozempic und Co, aber verträglicher ist. Es senkt den Appetit und hilft beim Abnehmen. <a href="https://nrw.social/tags/Ozempic" class="mention hashtag" rel="nofollow noopener" target="_blank">#Ozempic</a> <a href="https://nrw.social/tags/Semaglutid" class="mention hashtag" rel="nofollow noopener" target="_blank">#Semaglutid</a> <a href="https://nrw.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://nrw.social/tags/Abnehmspritze" class="mention hashtag" rel="nofollow noopener" target="_blank">#Abnehmspritze</a> <a href="https://nrw.social/tags/Abnehmen" class="mention hashtag" rel="nofollow noopener" target="_blank">#Abnehmen</a> <a href="https://www.scinexx.de/news/medizin/neue-abnehmspritze-ohne-nebenwirkungen/" rel="nofollow noopener" translate="no" target="_blank">https://www.scinexx.de/news/medizin/neue-abnehmspritze-ohne-nebenwirkungen/</a>

BedastGPTTo be clear: Ozempic is a diabetes drug while Wegovy is the weight loss counterpart. This “new" molecule does NOT address glucose management by improving sensitivity to insulin nor improving insulin response to the consumption of carbs. This new molecule will also NOT have a protective nor regenerative effect on pancreatic beta cell islets as GLP-1 does.This, strictly, appears to target satiety for weight loss.The only relation to semaglutide is that it's a peptide and it promotes weight loss. It has no other similarites with GLP-1. The comparison only exists to indicate efficacy of intended effect.<a href="https://beige.party/tags/Diabetes" class="mention hashtag" rel="nofollow noopener" target="_blank">#Diabetes</a> <a href="https://beige.party/tags/Ozempic" class="mention hashtag" rel="nofollow noopener" target="_blank">#Ozempic</a> <a href="https://beige.party/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://twit.social/@twitnews/114138689351869590" rel="nofollow noopener" translate="no" target="_blank">https://twit.social/@twitnews/114138689351869590</a>

Yonhap Infomax NewsUS biotech firm Terns Pharmaceuticals sees potential 5-fold stock increase on promising obesity drug developments and analyst optimism <a href="https://mastodon.social/tags/YonhapInfomax" class="mention hashtag" rel="nofollow noopener" target="_blank">#YonhapInfomax</a> <a href="https://mastodon.social/tags/TernsPharmaceuticals" class="mention hashtag" rel="nofollow noopener" target="_blank">#TernsPharmaceuticals</a> <a href="https://mastodon.social/tags/ObesityDrug" class="mention hashtag" rel="nofollow noopener" target="_blank">#ObesityDrug</a> <a href="https://mastodon.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://mastodon.social/tags/StockForecast" class="mention hashtag" rel="nofollow noopener" target="_blank">#StockForecast</a> <a href="https://mastodon.social/tags/BiotechIndustry" class="mention hashtag" rel="nofollow noopener" target="_blank">#BiotechIndustry</a> <a href="https://mastodon.social/tags/Economics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Economics</a> <a href="https://mastodon.social/tags/FinancialMarkets" class="mention hashtag" rel="nofollow noopener" target="_blank">#FinancialMarkets</a> <a href="https://mastodon.social/tags/Banking" class="mention hashtag" rel="nofollow noopener" target="_blank">#Banking</a> <a href="https://mastodon.social/tags/Securities" class="mention hashtag" rel="nofollow noopener" target="_blank">#Securities</a> <a href="https://mastodon.social/tags/Bonds" class="mention hashtag" rel="nofollow noopener" target="_blank">#Bonds</a> <a href="https://mastodon.social/tags/StockMarket" class="mention hashtag" rel="nofollow noopener" target="_blank">#StockMarket</a> <a href="https://en.infomaxai.com/news/articleView.html?idxno=53550" rel="nofollow noopener" translate="no" target="_blank">https://en.infomaxai.com/news/articleView.html?idxno=53550</a>

Brittany TrangSome patients in trials for the newest weight-loss drugs are losing ~too much~ weight, eating peanut butter and skipping doses to avoid losing more.But that conflicts with the industry's hunger for ever-larger weight loss percentages. How are those two interests getting reconciled? <a href="https://www.statnews.com/2025/02/20/too-much-weight-loss-in-obesity-drug-trial-market-pressure-to-outperform-wegovy-zepbound/" rel="nofollow noopener" translate="no" target="_blank">https://www.statnews.com/2025/02/20/too-much-weight-loss-in-obesity-drug-trial-market-pressure-to-outperform-wegovy-zepbound/</a> <a href="https://newsie.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener" target="_blank">#GLP1</a> <a href="https://newsie.social/tags/obesity" class="mention hashtag" rel="nofollow noopener" target="_blank">#obesity</a> <a href="https://newsie.social/tags/weightloss" class="mention hashtag" rel="nofollow noopener" target="_blank">#weightloss</a> <a href="https://newsie.social/tags/health" class="mention hashtag" rel="nofollow noopener" target="_blank">#health</a> <a href="https://newsie.social/tags/healthcare" class="mention hashtag" rel="nofollow noopener" target="_blank">#healthcare</a> <a href="https://newsie.social/tags/medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#medicine</a>

Recent searches

Search options

Administered by:

Server stats:

#glp1